Torisel and Cerebral haemorrhage - a phase IV clinical study of FDA data

Summary:

Cerebral haemorrhage is reported as a side effect among people who take Torisel (temsirolimus), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Decadron, and have Renal cell carcinoma.

The phase IV clinical study analyzes which people have Cerebral haemorrhage when taking Torisel. It is created by eHealthMe based on reports of 3,194 people who have side effects when taking Torisel from the FDA, and is updated regularly.

What is Torisel?

Torisel has active ingredients of temsirolimus. eHealthMe is studying from 3,205 Torisel users. Check the latest studies of Torisel.

What is Cerebral haemorrhage?

Cerebral haemorrhage (bleeding within the brain) is found to be associated with 1,435 drugs and 1,502 conditions by eHealthMe. Check the latest studies of Cerebral haemorrhage.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

3,194 people reported to have side effects when taking Torisel.
Among them, 18 people (0.56%) have Cerebral haemorrhage.

Could Torisel cause Cerebral haemorrhage?

Among these 18 people:

How long have people been on Torisel when they have Cerebral haemorrhage? *

What is the gender of people who have Cerebral haemorrhage when taking Torisel? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Cerebral haemorrhage when taking Torisel? *

What are other drugs people take besides Torisel? *

What are other side effects people have besides Cerebral haemorrhage? *

Oedema (fluid collection in tissue): 2 people, 11.11%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 11.11%
Pleural Effusion (water on the lungs): 2 people, 11.11%
Death: 2 people, 11.11%
Weight Decreased: 1 person, 5.56%
Fall: 1 person, 5.56%
Diarrhea: 1 person, 5.56%
Disability: 1 person, 5.56%
Disease Progression: 1 person, 5.56%
Drowsiness: 1 person, 5.56%

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 6 people, 33.33%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 3 people, 16.67%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 2 people, 11.11%
Malignant Melanoma (skin cancer rises from melancytes): 2 people, 11.11%
High Blood Pressure: 2 people, 11.11%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 11.11%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 5.56%
Renal Cell Carcinoma Stage Unspecified (kidney cancer in unknown stage): 1 person, 5.56%
Prostate Cancer: 1 person, 5.56%
Pneumocystis Jiroveci Pneumonia (fungal infection of the lungs): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Torisel and have Cerebral haemorrhage?

- Check whether Cerebral haemorrhage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Torisel:

Torisel (3,205 reports)

Browse all side effects of Torisel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cerebral haemorrhage:

Cerebral haemorrhage (1,435 drugs)

Browse all the conditions that are associated with Cerebral haemorrhage:

Cerebral haemorrhage (1,502 conditions)

Related publications that referenced our studies

Herrin MA, Rubinstein JC, Christison-Lagay ER, "Temsirolimus therapy and small bowel perforation in a pediatric patient with Clostridium septicum bacteremia", Journal of Pediatric Surgery Case Reports, 2015 Aug .
Herrin MA, Rubinstein JC, Christison-Lagay ER, "Temsirolimus therapy and small bowel perforation in a pediatric patient with Clostridium septicum bacteremia", Journal of Pediatric Surgery Case Reports, 2015 Aug .

How the study uses the data?

The study uses data from the FDA. It is based on temsirolimus (the active ingredients of Torisel) and Torisel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.